OMB
No.: 0925-XXXX Expiration
Date: xx/xx/20xx Collection
of this information is authorized by The Public Health Service Act,
Section 410 (42 USC 285). Rights of participants are protected by
The Privacy Act of 1974. Participation is voluntary, and there are
no penalties for not participating or withdrawing from the study at
any time. The information collected in this study will be kept
private to the extent provided by law. Names and other identifiers
will not appear in any report of the study. Information provided
will be combined for all participants and reported as summaries.
You are being contacted by telephone to complete this interview as
part of a full-scale evaluation of the IMAT Program.
Public
reporting burden for this collection of information is estimated to
average 60 minutes per response, including the time for reviewing
instructions, searching existing data sources, gathering and
maintaining the data needed, and completing and reviewing the
collection of information. An
agency may not conduct or sponsor, and a person is not required to
respond to, a collection of information unless it displays a
currently valid OMB control number.
Send comments regarding this burden estimate or any other aspect of
this collection of information, including suggestions for reducing
this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive,
MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-XXXX). Do not
return the completed form to this address.
My name is __________________, and I’m a member of the project team working with the National Cancer Institute (NCI) to evaluate the Innovative Molecular Analysis Technologies (IMAT) Program. NCI is conducting a full-scale evaluation of the IMAT Program. I work for __________, a research and evaluation firm in _________, charged with the task of conducting this evaluation. We greatly appreciate your willingness to answer a few questions about the IMAT Program and the technology funded by the IMAT award.
We realize that your time is valuable, so let’s get started.
The first few questions are intended to help us understand the origins of your technology and relationship with other existing technologies.
How was the idea for this technology generated? (e.g., was it part of any of your earlier grants?)
Click here to enter text.
How did the technology/research you proposed relate to earlier technologies?
Click here to enter text.
Please describe the advantages of this technology/research compared to existing technologies.
Click here to enter text.
[When you applied for the grant] What did you envision as the eventual outcome of this technology (e.g., how it could be used)?
Click here to enter text.
The next few questions are related to the grant application process.
Describe your experience framing your idea into the context, themes and structure of the IMAT program. Was the process easy or challenging?
Click here to enter text.
Would you have pursued development of this particular technology without IMAT funding?
☐ Yes ☐ No
[If yes] What mechanisms or funding sources would you have pursued/used?
Click here to enter text.
[**If R21 and/or R33**] Did/would you prefer the coupled application process to the current uncoupled application process? Why or Why not?
Click here to enter text.
Please provide any thoughts on your experience in submitting your application to the IMAT program related to clarity of the solicitation.
Click here to enter text.
Please provide any thoughts on your experience in submitting your application to the IMAT program related to the quality of the review process.
Click here to enter text.
Please provide any thoughts on your experience in submitting your application to the IMAT program related to appropriateness of the IMAT program structure and your research goals.
Click here to enter text.
The next few questions are related to the technology/research you developed during the grant period.
Please describe your technology in terms of the novel platforms and chemical methodologies you developed (i.e., what was the new measurement capability that you introduced and what were the new components you developed to make it possible) during the grant period.
Click here to enter text.
Please describe how you advanced the research/technology from the start of the grant to the end of the grant (e.g., did you make specific discoveries that accelerated progress on your project aims?).
[Information will be pre-populated from annual progress reports where possible to reduce respondent burden.]
Click here to enter text.
How did the research environment at your organization or institution (e.g., institutional support, other related research activities) impact the development of your technology during the grant?
Click here to enter text.
The next few questions are related to interactions with other researchers outside your organization or department.
During the grant period, do/did you use your technology to pursue new research with other departments or centers at your organization?
☐ Yes ☐ No
[If so] With whom? [specify name, department, current institution]
Click here to enter text.
Have you, or did you, collaborate with other organizations outside your current organization to advance the technology during the grant?
☐ Yes ☐ No
[If so] With whom? [specify name, department, current institution]
Click here to enter text.
[If so] Did these collaborative relationship exist before the IMAT grant?
☐ Yes
☐ No
☐ Some, but not all
Please describe up to three (3) of your most useful collaborative relationships in terms of advancing your technology.
Click here to enter text.
How were these collaborative relationships initiated?
Click here to enter text.
Do any of your collaborations include colleagues from other disciplines?
☐ Yes ☐ No
[If yes] Please specify the relevant disciplines:
Click here to enter text.
The annual IMAT PI meeting is intended to be a forum to talk with colleagues and NIH staff to help advance your work and technology. Did you attend the annual PI meeting during your grant period?
☐ Yes
☐ No
[If yes] What would you recommendation for making the annual PI meeting more useful or productive?
Click here to enter text.
These questions are intended to help us identify ways in which your technology is being applied or disseminated.
Did you achieve all of the aims specified in your IMAT grant?
☐ Yes ☐ No
[If not] What were the challenges you experienced?
Click here to enter text.
Would technical assistance have been useful to you?
Click here to enter text.
Could you describe some ways in which you have been able to apply your research/technology since grant award?
Click here to enter text.
Are you aware of an impact that your activities have had on other researchers in the field?
☐ Yes ☐ No
[If so] Please describe.
Click here to enter text.
There are three broad and concluding questions left for you.
How could NCI further assist investigators in developing or disseminating their research/technologies?
Click here to enter text.
Do you have any additional comments or concerns related to the IMAT program that we did not cover today? [If so] Please explain.
Click here to enter text.
Do you have any questions or concerns related to this interview or the evaluation of the IMAT program?
Click here to enter text.
Thank you for the time and input today.
1 The evaluation team will prepopulate information where possible using existing data sources such as the individual’s summary statement.
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Julia Rollison |
| File Modified | 0000-00-00 |
| File Created | 2021-01-25 |